K.J. Harrison & Partners Inc Buys 8,020 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

K.J. Harrison & Partners Inc increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 432.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 9,875 shares of the healthcare conglomerate's stock after buying an additional 8,020 shares during the quarter. UnitedHealth Group accounts for approximately 1.0% of K.J. Harrison & Partners Inc's holdings, making the stock its 25th largest holding. K.J. Harrison & Partners Inc's holdings in UnitedHealth Group were worth $5,172,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in UNH. Guardian Asset Advisors LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at about $201,000. Capital Advisors Wealth Management LLC grew its holdings in UnitedHealth Group by 10.8% during the first quarter. Capital Advisors Wealth Management LLC now owns 658 shares of the healthcare conglomerate's stock worth $345,000 after purchasing an additional 64 shares during the period. Patron Partners LLC grew its holdings in UnitedHealth Group by 3.9% during the first quarter. Patron Partners LLC now owns 2,060 shares of the healthcare conglomerate's stock worth $1,079,000 after purchasing an additional 78 shares during the period. Mendel Capital Management LLC grew its holdings in UnitedHealth Group by 5.9% during the first quarter. Mendel Capital Management LLC now owns 1,075 shares of the healthcare conglomerate's stock worth $563,000 after purchasing an additional 60 shares during the period. Finally, Confluence Wealth Services Inc. grew its holdings in UnitedHealth Group by 8.9% during the first quarter. Confluence Wealth Services Inc. now owns 7,480 shares of the healthcare conglomerate's stock worth $3,918,000 after purchasing an additional 612 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $308.85 on Friday. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The company's 50-day moving average is $336.21 and its 200 day moving average is $453.97. The stock has a market capitalization of $280.17 billion, a P/E ratio of 12.93, a P/E/G ratio of 1.46 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group's dividend payout ratio is 37.02%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now directly owns 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Finally, TD Securities restated a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $415.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.